Evan David Seigerman, managing director of BioPharma Equity Research at BMO, joins BNN Bloomberg with a roundup of first-quarter pharmaceutical earnings. He also shares his top 3 pharma stock picks including Eli Lilly.
Watch/Read More
Categories